Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protocadherin alpha-4 is a neural cadherin-like cell adhesion protein encoded by the PCDHA4 gene, part of the protocadherin alpha gene cluster located on human chromosome 5[1][3]. It is an integral plasma membrane protein with six extracellular cadherin ectodomains and a cytoplasmic domain, and is expressed primarily in the brain. Protocadherin alpha-4 is thought to play a critical role in the establishment and function of specific cell-cell connections important for neural circuit assembly, through strict homophilic (like-with-like) recognition and adhesion among neurons[1][3][4]. These interactions are essential for neuronal self-recognition and the molecular individuality of neurons, which underlies the precision of neural wiring in the vertebrate brain[4]. Disruptions in protocadherin family members, including PCDHA4, have been associated with neurodevelopmental and neuropsychiatric disorders. No approved drugs or chemical probes are known to interact with this protein, and it is not a current therapeutic target in the classical sense (such as a receptor or enzyme), but its biological functions are crucial for normal brain development and maintenance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protocadherin alpha-4 (PCDHA4).